The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity

The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective in vivo inhibition of th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology and applied pharmacology 1989-09, Vol.100 (3), p.517-528
Hauptverfasser: van Ommen, Ben, Hendriks, Willem, Bessems, Jos G.M., Geesink, Geert, Müller, Franz, van Bladeren, Peter J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 528
container_issue 3
container_start_page 517
container_title Toxicology and applied pharmacology
container_volume 100
creator van Ommen, Ben
Hendriks, Willem
Bessems, Jos G.M.
Geesink, Geert
Müller, Franz
van Bladeren, Peter J.
description The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol. In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene.
doi_str_mv 10.1016/0041-008X(89)90299-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15440171</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0041008X89902998</els_id><sourcerecordid>15440171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</originalsourceid><addsrcrecordid>eNp9kF1rHCEUhiWkpNs0fyCk4EUp7cW06rij3hRK6BcEctEEeieOc8waZnWjbprtr4_TWfayV8p5n3N4eRC6oOQjJbT7RAinDSHy93upPijClGrkEVpQorqGtG17jBYH5CV6lfM9IURxTk_QCROy_toFur9ZAU4wmuJjwD2UPwABlzqMT36o00fAvY8lmZBdTOuZiw6v4MnY1RhT7CH8hQDYhAH7kvEmps1ql3yIdxC8xcbWK77sXqMXzowZzvbvKbr99vXm8kdzdf395-WXq8YuCSvNwKQ1wkEnJBNuGGTPOmasYND2jHMJyjmwtBNcECmYEMYx1Rq1ZIr1PWPtKXo3392k-LCFXPTaZwvjaALEbdZ0yTmhglaQz6BNMecETm-SX5u005ToSbGe_OnJn5ZK_1OsZV17s7-_7dcwHJb2Tmv-dp-bbM3oqjrr8wHrOsqVmrDzGXMmanOXKnL7S9Vikk7VPs8hVFGPHpLO1kOwMPgEtugh-v-XfAaFsKJ8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15440171</pqid></control><display><type>article</type><title>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>van Ommen, Ben ; Hendriks, Willem ; Bessems, Jos G.M. ; Geesink, Geert ; Müller, Franz ; van Bladeren, Peter J.</creator><creatorcontrib>van Ommen, Ben ; Hendriks, Willem ; Bessems, Jos G.M. ; Geesink, Geert ; Müller, Franz ; van Bladeren, Peter J.</creatorcontrib><description>The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol. In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/0041-008X(89)90299-8</identifier><identifier>PMID: 2789443</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; Biotransformation ; Chemical and Drug Induced Liver Injury ; Chemical and industrial products toxicology. Toxic occupational diseases ; Chlorobenzenes - pharmacokinetics ; COMPOSE ORGANOCHLORE ; COMPUESTO ORGANICO DEL CLORO ; Cytochrome P-450 Enzyme Inhibitors ; CYTOCHROME P450 ; CYTOCHROMES ; Female ; FONGICIDE ; FUNGICIDAS ; FUNGICIDES ; Hexachlorobenzene - pharmacokinetics ; Hexachlorobenzene - toxicity ; HYDROQUINONES ; Hydroquinones - metabolism ; In Vitro Techniques ; INHIBITORS ; Liver Diseases - metabolism ; Male ; Medical sciences ; METABOLITE ; METABOLITES ; METABOLITOS ; METALLOPROTEINE ; METALLOPROTEINS ; METALPROTEINAS ; Microsomes, Liver - metabolism ; ORGANOCHLORINE COMPOUNDS ; OXIDACION ; OXIDATION ; Oxidation-Reduction ; OXYDATION ; PCP ; Pentachlorophenol - metabolism ; PORFIRINAS ; Porphyrias - chemically induced ; Porphyrias - metabolism ; PORPHYRINE ; PORPHYRINS ; QUINONAS ; QUINONE ; QUINONES ; RAT ; RATA ; RATS ; Rats, Inbred Strains ; Toxicology ; TRIOCETYLOLEANDOMYCIN ; Troleandomycin - pharmacology ; Various organic compounds</subject><ispartof>Toxicology and applied pharmacology, 1989-09, Vol.100 (3), p.517-528</ispartof><rights>1989</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</citedby><cites>FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0041-008X(89)90299-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6614993$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2789443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Ommen, Ben</creatorcontrib><creatorcontrib>Hendriks, Willem</creatorcontrib><creatorcontrib>Bessems, Jos G.M.</creatorcontrib><creatorcontrib>Geesink, Geert</creatorcontrib><creatorcontrib>Müller, Franz</creatorcontrib><creatorcontrib>van Bladeren, Peter J.</creatorcontrib><title>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol. In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biotransformation</subject><subject>Chemical and Drug Induced Liver Injury</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Chlorobenzenes - pharmacokinetics</subject><subject>COMPOSE ORGANOCHLORE</subject><subject>COMPUESTO ORGANICO DEL CLORO</subject><subject>Cytochrome P-450 Enzyme Inhibitors</subject><subject>CYTOCHROME P450</subject><subject>CYTOCHROMES</subject><subject>Female</subject><subject>FONGICIDE</subject><subject>FUNGICIDAS</subject><subject>FUNGICIDES</subject><subject>Hexachlorobenzene - pharmacokinetics</subject><subject>Hexachlorobenzene - toxicity</subject><subject>HYDROQUINONES</subject><subject>Hydroquinones - metabolism</subject><subject>In Vitro Techniques</subject><subject>INHIBITORS</subject><subject>Liver Diseases - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>METABOLITE</subject><subject>METABOLITES</subject><subject>METABOLITOS</subject><subject>METALLOPROTEINE</subject><subject>METALLOPROTEINS</subject><subject>METALPROTEINAS</subject><subject>Microsomes, Liver - metabolism</subject><subject>ORGANOCHLORINE COMPOUNDS</subject><subject>OXIDACION</subject><subject>OXIDATION</subject><subject>Oxidation-Reduction</subject><subject>OXYDATION</subject><subject>PCP</subject><subject>Pentachlorophenol - metabolism</subject><subject>PORFIRINAS</subject><subject>Porphyrias - chemically induced</subject><subject>Porphyrias - metabolism</subject><subject>PORPHYRINE</subject><subject>PORPHYRINS</subject><subject>QUINONAS</subject><subject>QUINONE</subject><subject>QUINONES</subject><subject>RAT</subject><subject>RATA</subject><subject>RATS</subject><subject>Rats, Inbred Strains</subject><subject>Toxicology</subject><subject>TRIOCETYLOLEANDOMYCIN</subject><subject>Troleandomycin - pharmacology</subject><subject>Various organic compounds</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1rHCEUhiWkpNs0fyCk4EUp7cW06rij3hRK6BcEctEEeieOc8waZnWjbprtr4_TWfayV8p5n3N4eRC6oOQjJbT7RAinDSHy93upPijClGrkEVpQorqGtG17jBYH5CV6lfM9IURxTk_QCROy_toFur9ZAU4wmuJjwD2UPwABlzqMT36o00fAvY8lmZBdTOuZiw6v4MnY1RhT7CH8hQDYhAH7kvEmps1ql3yIdxC8xcbWK77sXqMXzowZzvbvKbr99vXm8kdzdf395-WXq8YuCSvNwKQ1wkEnJBNuGGTPOmasYND2jHMJyjmwtBNcECmYEMYx1Rq1ZIr1PWPtKXo3392k-LCFXPTaZwvjaALEbdZ0yTmhglaQz6BNMecETm-SX5u005ToSbGe_OnJn5ZK_1OsZV17s7-_7dcwHJb2Tmv-dp-bbM3oqjrr8wHrOsqVmrDzGXMmanOXKnL7S9Vikk7VPs8hVFGPHpLO1kOwMPgEtugh-v-XfAaFsKJ8</recordid><startdate>19890915</startdate><enddate>19890915</enddate><creator>van Ommen, Ben</creator><creator>Hendriks, Willem</creator><creator>Bessems, Jos G.M.</creator><creator>Geesink, Geert</creator><creator>Müller, Franz</creator><creator>van Bladeren, Peter J.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19890915</creationdate><title>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</title><author>van Ommen, Ben ; Hendriks, Willem ; Bessems, Jos G.M. ; Geesink, Geert ; Müller, Franz ; van Bladeren, Peter J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biotransformation</topic><topic>Chemical and Drug Induced Liver Injury</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Chlorobenzenes - pharmacokinetics</topic><topic>COMPOSE ORGANOCHLORE</topic><topic>COMPUESTO ORGANICO DEL CLORO</topic><topic>Cytochrome P-450 Enzyme Inhibitors</topic><topic>CYTOCHROME P450</topic><topic>CYTOCHROMES</topic><topic>Female</topic><topic>FONGICIDE</topic><topic>FUNGICIDAS</topic><topic>FUNGICIDES</topic><topic>Hexachlorobenzene - pharmacokinetics</topic><topic>Hexachlorobenzene - toxicity</topic><topic>HYDROQUINONES</topic><topic>Hydroquinones - metabolism</topic><topic>In Vitro Techniques</topic><topic>INHIBITORS</topic><topic>Liver Diseases - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>METABOLITE</topic><topic>METABOLITES</topic><topic>METABOLITOS</topic><topic>METALLOPROTEINE</topic><topic>METALLOPROTEINS</topic><topic>METALPROTEINAS</topic><topic>Microsomes, Liver - metabolism</topic><topic>ORGANOCHLORINE COMPOUNDS</topic><topic>OXIDACION</topic><topic>OXIDATION</topic><topic>Oxidation-Reduction</topic><topic>OXYDATION</topic><topic>PCP</topic><topic>Pentachlorophenol - metabolism</topic><topic>PORFIRINAS</topic><topic>Porphyrias - chemically induced</topic><topic>Porphyrias - metabolism</topic><topic>PORPHYRINE</topic><topic>PORPHYRINS</topic><topic>QUINONAS</topic><topic>QUINONE</topic><topic>QUINONES</topic><topic>RAT</topic><topic>RATA</topic><topic>RATS</topic><topic>Rats, Inbred Strains</topic><topic>Toxicology</topic><topic>TRIOCETYLOLEANDOMYCIN</topic><topic>Troleandomycin - pharmacology</topic><topic>Various organic compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Ommen, Ben</creatorcontrib><creatorcontrib>Hendriks, Willem</creatorcontrib><creatorcontrib>Bessems, Jos G.M.</creatorcontrib><creatorcontrib>Geesink, Geert</creatorcontrib><creatorcontrib>Müller, Franz</creatorcontrib><creatorcontrib>van Bladeren, Peter J.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Ommen, Ben</au><au>Hendriks, Willem</au><au>Bessems, Jos G.M.</au><au>Geesink, Geert</au><au>Müller, Franz</au><au>van Bladeren, Peter J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>1989-09-15</date><risdate>1989</risdate><volume>100</volume><issue>3</issue><spage>517</spage><epage>528</epage><pages>517-528</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol. In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>2789443</pmid><doi>10.1016/0041-008X(89)90299-8</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 1989-09, Vol.100 (3), p.517-528
issn 0041-008X
1096-0333
language eng
recordid cdi_proquest_miscellaneous_15440171
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Biological and medical sciences
Biotransformation
Chemical and Drug Induced Liver Injury
Chemical and industrial products toxicology. Toxic occupational diseases
Chlorobenzenes - pharmacokinetics
COMPOSE ORGANOCHLORE
COMPUESTO ORGANICO DEL CLORO
Cytochrome P-450 Enzyme Inhibitors
CYTOCHROME P450
CYTOCHROMES
Female
FONGICIDE
FUNGICIDAS
FUNGICIDES
Hexachlorobenzene - pharmacokinetics
Hexachlorobenzene - toxicity
HYDROQUINONES
Hydroquinones - metabolism
In Vitro Techniques
INHIBITORS
Liver Diseases - metabolism
Male
Medical sciences
METABOLITE
METABOLITES
METABOLITOS
METALLOPROTEINE
METALLOPROTEINS
METALPROTEINAS
Microsomes, Liver - metabolism
ORGANOCHLORINE COMPOUNDS
OXIDACION
OXIDATION
Oxidation-Reduction
OXYDATION
PCP
Pentachlorophenol - metabolism
PORFIRINAS
Porphyrias - chemically induced
Porphyrias - metabolism
PORPHYRINE
PORPHYRINS
QUINONAS
QUINONE
QUINONES
RAT
RATA
RATS
Rats, Inbred Strains
Toxicology
TRIOCETYLOLEANDOMYCIN
Troleandomycin - pharmacology
Various organic compounds
title The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T09%3A53%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20relation%20between%20the%20oxidative%20biotransformation%20of%20hexachlorobenzene%20and%20its%20porphyrinogenic%20activity&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=van%20Ommen,%20Ben&rft.date=1989-09-15&rft.volume=100&rft.issue=3&rft.spage=517&rft.epage=528&rft.pages=517-528&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1016/0041-008X(89)90299-8&rft_dat=%3Cproquest_cross%3E15440171%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15440171&rft_id=info:pmid/2789443&rft_els_id=0041008X89902998&rfr_iscdi=true